12.02.25 -- STREAM Edition: Biotech Funding And IPO Temperature Check

In this first segment of Cell & Gene Live, Optimizing Storage Solutions for iPSCs, expert panelists focus on best practices for translating laboratory development processes into CGMP manufacturing settings.

Accelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.

Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.

Discover an end-to-end solution that digitally integrates two automated, functionally closed systems and supports autologous CAR T cell therapy manufacturing from clinical to commercial.

A risk-based framework for identity testing of ancillary raw materials in gene therapy is presented, with emphasis on implementation based on product contact, material classification, and manufacturing stage.

Learn how to accurately sample from the PBS Mini bioreactor. Discover critical steps for representative samples, including optimal mixing and collection techniques.

Allan Shaw, Chief Financial Officer and Chief Business Officer at Create Medicines, is back on the Business of Biotech this week, with a temperature check on biotech funding and the IPO market.